![Derval O'Carroll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derval O'Carroll
Compliance Officer at
INFLARX N.V.
Net worth: - $ as of 29/06/2026
Profile
Derval O'Carroll currently works at InflaRx NV, as SVP, Head-Global Regulatory Affairs & Compliance from 2022.
Ms. O'Carroll also formerly worked at Travere Therapeutics, Inc., as Senior Director-Regulatory Affairs from 2015 to 2017, Amryt Pharma Holdings Ltd., as Head-Regulatory Affairs, and Amryt Pharma Plc, as Head-Regulatory Affairs.
Ms. O'Carroll received her graduate degree and Masters Business Admin degree from University College Dublin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INFLARX N.V. -.--% | 17/03/2026 | 0 ( -.--% ) | - $ | 29/06/2026 |
Derval O'Carroll active positions
| Companies | Position | Start |
|---|---|---|
| INFLARX N.V. | Compliance Officer | 31/12/2021 |
Former positions of Derval O'Carroll
| Companies | Position | End |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | General Counsel | 30/11/2017 |
| AMRYT PHARMA PLC | General Counsel | - |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | General Counsel | - |
Training of Derval O'Carroll
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
- Stock Market
- Insiders
- Derval O'Carroll
